Update on Disruption in Operations at come of the Manufacturing Sites at Haridwar
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals has confirmed that manufacturing operations at affected sites in Haridwar, Uttarakhand, have fully resumed at 100% capacity from May 18, 2026. The partial disruption lasted four days and caused delayed supply of approximately INR 20 Crores. No property damage occurred, and the company does not plan to file an insurance claim. The disruption affected the company's own sites as well as its subsidiaries. Management expects to recover the lost production in the coming weeks.
The disruption is expected to be temporary with minimal financial impact since operations are fully restored. The INR 20 Crore supply delay should be recoverable, which is positive for shareholders concerned about the incident.